Filing Details

Accession Number:
0001209191-18-060179
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-28 20:51:03
Reporting Period:
2018-11-26
Accepted Time:
2018-11-28 20:51:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1305253 Eiger Biopharmaceuticals Inc. EIGR Biological Products, (No Disgnostic Substances) (2836) 361004130
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1686952 Iii C. Eldon Mayer C/O Eiger Biopharmaceuticals, Inc.
2155 Park Boulevard
Palo Alto CA 94306
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-26 7,500 $9.75 7,500 No 4 P Direct
Common Stock Acquisiton 2018-11-27 7,500 $9.92 15,000 No 4 P Direct
Common Stock Acquisiton 2001-11-28 6,000 $10.07 21,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $9.57 to $9.99 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 2 and 3 to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $9.77 to $10.09 inclusive.
  3. The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $9.7495 to $10.26 inclusive.